Analyst Insight: 2009 was filled with mergers and acquisitions led by mega mergers. During this time, the definition of "pharmaceutical company" evolved, as the big players began morphing into global health care providers. As the evolution continues, processes for integrating multinational supply chains, new product lines, and rationalizing LSP contracts will challenge even the most capable and visionary supply chain executives.